Mer Scott
Quiz por , criado more than 1 year ago

PHCY310 Quiz sobre L16 Therapeutics of Asthma, criado por Mer Scott em 12-04-2019.

8
0
0
Mer Scott
Criado por Mer Scott mais de 5 anos atrás
Fechar

L16 Therapeutics of Asthma

Questão 1 de 8

1

Clinical practice guidelines, meta-analysis, and systematic reviews are the highest ranked forms of evidence.

Selecione uma das opções:

  • VERDADEIRO
  • FALSO

Explicação

Questão 2 de 8

1

Māori are 3.4 times, and Pacific peoples 3.9 times, more likely to be admitted to hospital with asthma than Europeans or other New Zealanders.

Selecione uma das opções:

  • VERDADEIRO
  • FALSO

Explicação

Questão 3 de 8

1

When diagnosing asthma there is no single “gold standard” test, and we must assess the pattern of (wheezing, breathlessness, chest tightness, and coughing, particularly at or in the morning). We can also measure on more than one occasion, and assess to inhaled bronchodilator +/- inhaled corticosteroid.

Arraste e solte para completar o texto.

    signs and symptoms
    night
    early
    expiratory airflow
    response

Explicação

Questão 4 de 8

1

Ideal PEFR values depend on height and sex.

Selecione uma das opções:

  • VERDADEIRO
  • FALSO

Explicação

Questão 5 de 8

1

Which of these is NOT a principle of asthma treatment?

Selecione uma das seguintes:

  • Avoid triggers

  • Making an asthma plan

  • Drugs to improve ventilation

  • Drugs to decrease inflammation

  • Avoid exercise

Explicação

Questão 6 de 8

1

Goals of asthma treatment are about maintaining long-term control using the amount of medications and adverse effects.
We want to prevent chronic , require infrequent use ( or fewer days/week) of SABA, maintain normal or near-normal function and maintain levels. We should assure patients’ and families’ with asthma care. We also want to prevent exacerbations, the need for , and prevent progressive of lung function.

Arraste e solte para completar o texto.

    least
    minimising
    symptoms
    2
    pulmonary
    activity
    satisfaction
    hospitalisation
    loss

Explicação

Questão 7 de 8

1

Which of these is not a drug delivery device?

Selecione uma das seguintes:

  • Soft mist inhaler (SMI) - only with LAMA products in NZ

  • Nebuliser

  • Dry power inhaler (DPI)

  • Metered-dose inhaler (MDI) - spacer chamber

  • Dry mist inhaler (DMI)

Explicação

Questão 8 de 8

1

Treatment steps:
1. At initial diagnosis, all patients should use a , as required..
2. Add an if patients have symptoms for more than weeks. Often a big decision! (The usual dose in adults is /day.)
3. If control is not adequate, can be increased.
4. If control is not adequate, combine . ( can be used as a preventer and replace SABA.)

Patients can step up or down in order to achieve and maintain control.
Check adherence and inhaler at each step of the way!

Arraste e solte para completar o texto.

    SABA
    ICS
    two
    budesonide 400 mcg
    ICS dose
    ICS with a LABA
    Formoterol+budesonide
    technique

Explicação